How is the Blueprint Medicines Corp today?

The Blueprint Medicines Corp today is trading in the down by -1.66% at 101.35.

How has Blueprint Medicines Corp performed historically?

The Blueprint Medicines Corp is currently trading down -1.66% on an intraday basis in the past week the index fell -0.15%. The index has been up 4.95% in the past quarter and fell -3.99% in the past year. You can view this in the overview section.

What is Blueprint Medicines Corp Annual Revenue?

Blueprint Medicines Corp Annual Revenue rose 104.04%, in the last year to $508.82 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Blueprint Medicines Corp Annual Net Profit?

Blueprint Medicines Corp Annual Net Profit rose 86.77% in the last year to $67.09 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Blueprint Medicines Corp Price to Earning Ratio?

Blueprint Medicines Corp Price to Earning Ratio is -42.03, which is negative.

What is Blueprint Medicines Corp Stock Price?

Blueprint Medicines Corp Stock Price fell 3.99% and underperformed its sector by 59.46% in the past year.

What is Blueprint Medicines Corp Quarterly Revenue?

Blueprint Medicines Corp Quarterly Revenue rose 55.45% YoY to $149.41 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Blueprint Medicines Corp Quarterly Net profit?

Blueprint Medicines Corp Quarterly Net profit fell 99.44% YoY to $0.5 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Blueprint Medicines Corp Debt to Equity Ratio?

Blueprint Medicines Corp Debt to Equity Ratio of 1.57 is higher than 1. This implies that company assets are financed through debt.

What is Blueprint Medicines Corp Return on Equity(ROE)?

Blueprint Medicines Corp Return on Equity(ROE) for the last financial year was -31.26%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Blueprint Medicines Corp Mutual Fund Holding?

Blueprint Medicines Corp Mutual Fund Holding increased by 1.43% in the last quarter to 87.08.

What is Blueprint Medicines Corp Promoter Share Holding?

Blueprint Medicines Corp Promoter Share Holding increased by 0.1% in the most recent quarter to 1.82%.

What is Blueprint Medicines Corp Interest Coverage Ratio?

Blueprint Medicines Corp Interest Coverage Ratio is 0.04, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Blueprint Medicines Corp Institutional Holding?

Blueprint Medicines Corp Institutional Holding increased by 4.33% in the last quarter to 109.03.

Blueprint Medicines Corp XNAS: BPMC

Blueprint Medicines Corp Live Share Price Today, Share Analysis and Chart

Name: Blueprint Medicines Corp: Is Infosys Ltd. worth buying?
Item: Blueprint Medicines Corp
Rating: 1.708388875
Author: Trendlyne DVM scores

Expensive Performer

about

Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living wit...

101.35 -1.71 (-1.66%)

38.76% Gain from 52W Low

901.7K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Blueprint Medicines Corp is on 11 Jun 2025 for the purpose of Goldman Sachs 46th Annual Global Healthcare Conference See details

Medium Financial Strength

38.9 / 100

Expensive Valuation

6.3 / 100

Technically Neutral

52.6 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

126

1Yr Price target upside is 24%

20 analysts

Blueprint Medicines Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Blueprint Medicines Corp Live Share Price Today, Share Analysis and Chart

Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living wit...

38.76% Gain from 52W Low

SWOT Analysis

Blueprint Medicines Corp Live Price Chart

Blueprint Medicines Corp FAQ

How is Blueprint Medicines Corp today?

Blueprint Medicines Corp today is trading in the red, and is down by -1.66% at 101.35.

How has Blueprint Medicines Corp performed historically?

Blueprint Medicines Corp is currently trading down -1.66% on an intraday basis. In the past week the stock fell -0.15%. stock has been up 4.95% in the past quarter and fell -3.99% in the past year. You can view this in the overview section.